Methods apparatuses and systems for detecting and quantifying phosphoproteins
AssigneeOregon Health & Science University
InventorsTania Vu, Thomas Jacob, Brian J Druker
Life of this patent
Estimating the term…
Loading patent…
AssigneeOregon Health & Science University
InventorsTania Vu, Thomas Jacob, Brian J Druker
Estimating the term…
Embodiments herein provide methods, apparatuses, and systems for detecting, monitoring, measuring, and/or characterizing the activity of phosphoproteins such as tyrosine kinases (TKs) and downstream proteins in TK signal transduction pathways (e.g., TK pathway proteins). In various embodiments, the methods, apparatuses, and systems may use nanoparticles, such as quantum dots (QD), to detect and/or characterize the abnormally overactive TK signaling pathways that underlie tumorgenesis and tumor progression. In various embodiments, the QD-based methods, apparatuses, and systems may have a sufficiently high degree of sensitivity to enable the identification of new TK signaling pathway markers, for example for use in diagnosing, staging, monitoring, and/or prognosing cancers, or in evaluating the efficacy of cancer therapeutics.
A method of screening a drug for effectiveness in treating leukemia, the method comprising:
Dependencies are inferred from the claim text.